Prevalence of VIM- and GIM-producing Acinetobacter baumannii from patients with severe urinary tract infection

SAS Girija, VP Jayaseelan… - Acta microbiologica et …, 2018 - akjournals.com
Carbapenems are administered as the final drug of choice for treating complicated
nosocomial infections caused by multidrug-resistant Acinetobacter baumannii strains. It is …

[HTML][HTML] New perspectives on antibacterial drug research

J Ziemska, A Rajnisz, J Solecka - Open Life Sciences, 2013 - degruyter.com
Bacterial resistance to commonly used antibiotics is constantly increasing. Bacteria
particularly dangerous for human life are methicillin-resistant Staphylococcus aureus …

Prevalence of carbapenem-hydrolyzing OXA-type β-lactamases among Acinetobacter baumannii in patients with severe urinary tract infection

SA Girija, JV Priyadharsini… - Acta Microbiologica et …, 2020 - akjournals.com
Acinetobacter baumannii produces carbapenemase-hydrolyzing class D β-lactamases
(CHDLs) as one of the major drug resistance mechanisms. This investigation is thus aimed …

[HTML][HTML] In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of …

YF Hu, CP Liu, NY Wang, SC Shih - BMC infectious diseases, 2016 - Springer
Abstract Background Multidrug-resistant Pseudomonas aeruginosa has emerged as one of
the most important healthcare-associated pathogens. Colistin is regarded as the last-resort …

[HTML][HTML] Assessment of doripenem, meropenem, and imipenem against respiratory isolates of Pseudomonas aeroginosa in a tertiary care hospital of North India

A Negi, M Anand, A Singh, A Kumar… - Indian journal of …, 2017 - ncbi.nlm.nih.gov
Objective: Pseudomonas aeruginosa is one of the leading pathogen causing healthcare-
associated infections, particularly in immunocompromised and critically ill patients. The …

Activities of tobramycin and polymyxin E against Pseudomonas aeruginosa biofilm-coated medical grade endotracheal tubes

K Tarquinio, K Confreda, J Shurko… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Indwelling medical devices have become a major source of nosocomial infections,
especially Pseudomonas aeruginosa infections, which remain the most common cause of …

Successful treatment of post-neurosurgical multidrug-resistant Pseudomonas aeruginosa meningo-encephalitis with combination therapy of colistin, rifampicin and …

P Morelli, A Ferrario, F Tordato… - Journal of …, 2014 - academic.oup.com
Sir, A 40-year-old man with cerebral temporal fibrillary astrocytoma G2 underwent surgical
excision in 2007. Owing to local relapse, a new surgical intervention was performed in May …

Safety of high-dose doripenem in adult patients with cystic fibrosis

S Strawbridge, MD Nailor - Therapeutic Advances in Drug …, 2016 - journals.sagepub.com
Background: High doses of β-lactam antibiotics have been advocated for acute pulmonary
exacerbations caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF) …

Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other Carbapenem Antibiotics among Gram Negative Bacterial Isolates Obtained from VAP Patients …

M Bhatia, PS Loomba, B Mishra, V Dogra - Health Sciences, 2017 - indianjournals.com
Context: Few studies have been published about the in vitro Doripenem susceptibility
profiles of Gram negative bacteria obtained from lower respiratory tract samples of patients …

Antimicrobial Action of Herbal Products on Nosocomial, Multidrug Resistant, Metallo β-Lactamase and Carbapenemase Producing Acinetobacter and Their Molecular …

A Shivaprasad - 2017 - search.proquest.com
The genus Acinetobacter, largely unknown 30 years ago, has risen to prominence
particularly because of its ability to cause infection in immunocompromised patients. It has …